(Q46607014)

23 December 2017

title

The effects of multiple doses of fenofibrate on the pharmacokinetics of pravastatin and its 3alpha-hydroxy isomeric metabolite (English)

1 reference

23 December 2017

1 reference

Linda E Gustavson

1

1 reference

23 December 2017

Sarah M Schweitzer

2

1 reference

23 December 2017

Stephan Koehne-Voss

3

1 reference

23 December 2017

Ramanuj Achari

4

1 reference

23 December 2017

Titus O Chira

5

1 reference

23 December 2017

Hans-Ulrich Esslinger

6

1 reference

23 December 2017

H Daniel Yannicelli

7

1 reference

23 December 2017

publication date

1 August 2005

1 reference

23 December 2017

The Journal of Clinical Pharmacology

published in

1 reference

23 December 2017

volume

45

1 reference

23 December 2017

issue

8

1 reference

23 December 2017

page(s)

947-953

1 reference

23 December 2017

Micronised fenofibrate: an updated review of its clinical efficacy in the management of dyslipidaemia

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0091270005278085

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005278085

Long-term efficacy and safety of fenofibrate and a statin in the treatment of combined hyperlipidemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005278085

Gemfibrozil increases plasma pravastatin concentrations and reduces pravastatin renal clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005278085

Plasma concentrations of active lovastatin acid are markedly increased by gemfibrozil but not by bezafibrate

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005278085

Gemfibrozil greatly increases plasma concentrations of cerivastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005278085

Disposition of pravastatin sodium, a tissue-selective HMG-CoA reductase inhibitor, in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005278085

Gemfibrozil and its glucuronide inhibit the organic anion transporting polypeptide 2 (OATP2/OATP1B1:SLC21A6)-mediated hepatic uptake and CYP2C8-mediated metabolism of cerivastatin: analysis of the mechanism of the clinically relevant drug-drug inter

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005278085

A novel human hepatic organic anion transporting polypeptide (OATP2). Identification of a liver-specific human organic anion transporting polypeptide and identification of rat and human hydroxymethylglutaryl-CoA reductase inhibitor transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005278085

Pharmacokinetics of the combination of fluvastatin and gemfibrozil

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005278085

Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: consequences for pravastatin pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005278085

Evidence for inverse effects of OATP-C (SLC21A6) 5 and 1b haplotypes on pravastatin kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005278085

High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C (OATP-C, SLCO1B1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005278085

Clinical pharmacokinetics of pravastatin: mechanisms of pharmacokinetic events

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005278085

HMG-CoA reductase inhibitors (statins) characterized as direct inhibitors of P-glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0091270005278085

21 January 2018

Identifiers

DOI

10.1177/0091270005278085

1 reference

23 December 2017

1 reference

23 December 2017